CORD's Corporate Leaders Forum's role is to help ensure that Canada becomes a world leader in research, development and healthcare delivery for patients with rare disorders.

Purpose
The objective of the CORD Corporate Leaders Forum (CCLF) is to bring together leaders in the corporate community with leaders in the rare disorders patient community to explore issues of common concern and to work collaboratively to facilitate research, diagnosis, treatment, access to care, and prevention. CORD Corporate Leaders enjoy unique opportunities to network with researchers, clinicians, regulators, funders, and investors. And, as a member of the CORD Corporate Leaders Forum, you are identifying yourself as a corporation that values patient partnerships and investment in patient-centered healthcare.

Eligibility
All corporations doing business or interested in doing business in Canada related to rare disorders are urged to apply for membership in the CORD Corporate Leaders Forum. Research (joint) ventures, academic institutions, or nonprofit health-related associations may be considered for membership in CCLF. All corporate leaders are expected to abide by a code of conduct. Participation is on an annual basis.

Benefits of Corporate Leaders Forum
CORD Corporate Leaders have unique access to networks, forums and workshops convened by CORD on behalf of its patient organizations. As the recognized corporate advisory body to CORD, the CCLF may propose program initiatives, surveys, research studies, and partnership projects for the consideration of CORD or its affiliate member groups. Members of the CCLF do not have voting status at the Annual General Meeting. However, CCLF employees may join CORD as individual members with full privileges. Corporate Leaders Forum Members will have access to:

• Listing on CORD website (www.raredisorders.ca).
• Receive regular news updates and newsletters from CORD.
• Exclusive participation in CORD Corporate Leaders workshops and forums.
• Priority registration at CORD conferences, forums, and networking sessions.
  

Fees
Annual Corporate Leaders Forum membership is based on the
commitment level.

Membership Form
»Download Corporate Leaders Forum Membership Form

CORD is grateful to its Corporate Leaders Forum Members for their generosity. Through their contributions, CORD is able to continue its invaluable work.

Corporate Leaders Forum Members

Champion
Genzyme Canada Inc

Leader
Actelion Pharmaceuticals
Alexion Pharmaceuticals
Celgene
Enobia Pharma Inc.
Pfizer Inc

Supporter
Amgen Canada
Bayer
Bayshore Home Health
BioMarin Pharmaceutical Inc.
BIOTECanada
Gilead Sciences Canada Inc.
Ikaria
Medunik Canada Inc
Merck Frosst Canada Ltd.
Novartis Pharmaceuticals Canada
Ortho Biotech

Friend
Amicus Therapeutics Inc.
ApoPharma Inc.
Hoffmann-La Roche
Mark Krueger & Associates
Neurochem Inc.
Orfagen
PTC Therapeutics Inc.
Rare Disease Therapeutics
Santhera Pharmaceuticals
SHIRE Human Genetic Therapies
Sigma-Tau Pharmaceuticals Inc.